Dr. Liam Ratcliffe is listed as a director on 2 SEC Form D filings by 1 issuer in Mar 2010: Larimar Therapeutics, Inc. (Bala Cynwyd, PA — biotechnology — 2010; $82.1M reported sold to 24 investors).
What this means One deal on file with the SEC, filed Mar 2010. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Bruce Booth (2 shared filings), Kevin Starr (2 shared filings), Louis Tartaglia (2 shared filings), Matthias Jaffe (2 shared filings), Mitchell S. Bloom (2 shared filings) and 4 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Dr.. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 2 public filings for Dr. Liam Ratcliffe and found 1 difference: No amendment in the last 12 months on an offering that may still be open.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.